BackSofgen Pharma S.A. Overview
Sofgen Pharma S.A.

Sofgen Pharma S.A. Debt to Equity

Sofgen Pharma S.A. (PROCF) has a debt-to-equity ratio of 1568.16, above the Healthcare sector average of 0.3.

Get informed when a big investor buys or sells

+ Follow

Debt to Equity

1568.16

Debt to Equity

1568.16

Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.

Debt to Equity (Comparison Companies)

Loading

Debt to Equity History

Loading

Debt to Equity Comparison

Loading

Sofgen Pharma S.A. (PROCF) FAQ

The latest debt-to-equity ratio for PROCF is 1568.16. That is above the Healthcare sector average of 0.3. Investors often review this figure alongside Sofgen Pharma S.A.'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, PROCF currently prints 1568.16 for debt-to-equity ratio, while the sector average sits near 0.3. That is roughly 524006.5% above the sector mean. Large gaps often invite a closer look at Sofgen Pharma S.A.'s growth, margins, and balance sheet.

A debt-to-equity ratio of 1568.16 for Sofgen Pharma S.A. is not 'good' or 'bad' on its own. Compare it with the peer average (0.3) and with PROCF's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting PROCF's debt-to-equity ratio (1568.16), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Sofgen Pharma S.A.'s debt-to-equity ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.